Clinical Trials Logo
  1. Home
  2. Pancreatic Neoplasms
  3. NCT02869581
  4. Details
NCT02869581 Clinical Trial

Institut Paoli-Calmettes Pancreatic Neoplasms Database

Pancreatic Neoplasms Clinical Trial

Official title:
Institut Paoli-Calmettes Pancreatic Neoplasms Database

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02869581
Other study ID # BDD-PANCREAS-IPC
Secondary ID
Status Recruiting
Phase N/A
First received August 11, 2016
Last updated August 16, 2016
Start date January 2000
Est. completion date December 2030

Study information
Verified date August 2016
Source Institut Paoli-Calmettes
Contact Dominique Genre, MD
Phone 0033491223778
Email drci.up@ipc.unicancer.fr
Is FDA regulated No
Health authority France: Commission nationale de l'informatique et des libertés
Study type Observational [Patient Registry]

Clinical Trial Summary

Database of Institut Paoli Calmettes diagnosed with Pancreatic neoplasms

Recruitment information / eligibility
Status Recruiting
Enrollment 8500
Est. completion date December 2030
Est. primary completion date January 2030
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient with a diagnosis of Pancreatic neoplasm

Exclusion Criteria:

- Patient with a diagnosis of cholangiocarcinoma

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Other:
• Data collection

Locations
Country Name City State
France Institut Paoli Calmettes Marseille Bouches du Rhone

Sponsors (1)
Lead Sponsor Collaborator
Institut Paoli-Calmettes

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Survival of patients with pancreatic neoplasms Overall survival of all patients who come in the center 10 years No
Secondary Collection of patients characteristics Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies 10 years No
See also
  Status Clinical Trial Phase
Recruiting NCT04085055 - Fine Needle Biopsy of Solid Pancreatic Mass Lesions N/A
Recruiting NCT01950572 - Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Terminated NCT00529113 - Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer Phase 1
Recruiting NCT05351983 - Patient-derived Organoids Drug Screen in Pancreatic Cancer N/A
Recruiting NCT04809935 - EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy Phase 4
Recruiting NCT05481476 - Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer Phase 2
Not yet recruiting NCT04652271 - International Pancreatic Surgery Outcomes Study - PancreasGroup.Org
Active, not recruiting NCT02950064 - A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations Phase 1
Completed NCT02909530 - Comparison Between Olympus EZ Shot 3Plus 19G and EZ Shot 2 19G in EUS-guided FNB of Solid Pancreatic Masses N/A
Completed NCT03054987 - Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction N/A
Completed NCT02374411 - Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients N/A
Completed NCT01770405 - Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract N/A
Terminated NCT01313416 - Gemcitabine and CT-011 for Resected Pancreatic Cancer Phase 2
Terminated NCT01515046 - Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer Phase 2
Enrolling by invitation NCT01465425 - Extracolonic Findings on Computed Tomography (CT) Colonography
Terminated NCT01434459 - Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin Phase 1
Completed NCT00985777 - Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia Phase 1
Completed NCT00385177 - Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors Phase 1
Recruiting NCT00178763 - Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer Phase 2
Completed NCT00196105 - Malignant Obstruction ZILVER Against Routine Therapy (MOZART I) N/A